We are looking for children 2 to 17 years of age to join a CD clinical trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderately to severely active IBD (including associated symptoms such as diarrhea with blood, kidney stones, bloody stool, malnutrition and/or anemia), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
